CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: Safety, tolerability, and technical feasibility

Radiology

Volumn 266, Issue 2, 2013, Pages 592-598

  Spano, Vincent R ^a   Mandell, Daniel M ^a   Poublanc, Julien ^a   Sam, Kevin ^a   Battisti Charbonney, Anne ^a   Pucci, Olivia ^a   Han, Jay S ^a   Crawley, Adrian P ^a   Fisher, Joseph A ^b   Mikulis, David J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BOLD SIGNAL; CEREBROVASCULAR DISEASE; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIZZINESS; DYSPNEA; FEASIBILITY STUDY; FEMALE; HEAD MOVEMENT; HEADACHE; HUMAN; HYPERCAPNIA; IMAGE QUALITY; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; BLOOD; BRAIN CIRCULATION; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; CHILD; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; OXYGEN; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84873354005     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112795     Document Type: Article

References (37)

1. Schwertfeger N, Neu P, Schlattmann P, Lemke H, Heuser I, Bajbouj M. Cerebrovascular reactivity over time course in healthy subjects. J Neurol Sci 2006;249(2):135-139.
2. Goode SD, Krishan S, Alexakis C, Mahajan R, Auer DP. Precision of cerebrovascular reactivity assessment with use of different quantification methods for hypercapnia functional MR imaging. AJNR Am J Neuroradiol 2009;30(5):972-977.
3. Han JS, Mandell DM, Poublanc J, et al. BOLD-MRI cerebrovascular reactivity fndings in cocaine-induced cerebral vasculitis. Nat Clin Pract Neurol 2008;4(11):628-632.
4. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000;283(16):2122-2127.
5. Len TK, Neary JP, Asmundson GJ, Goodman DG, Bjornson B, Bhambhani YN. Cerebrovascular reactivity impairment after sport-induced concussion. Med Sci Sports Exerc 2011;43(12):2241-2248.
6. Han JS, Abou-Hamden A, Mandell DM, et al. Impact of extracranial- intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 2011;42(11):3047-3054.
7. Fierstra J, Conklin J, Krings T, et al. Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain 2011;134(Pt 1):100-109.
8. Marshall RS, Lazar RM. Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke 2011;42(1):221-226.
9. Minhas PS, Smielewski P, Kirkpatrick PJ, Pickard JD, Czosnyka M. Pressure autoregulation and positron emission tomographyderived cerebral blood fow acetazolamide reactivity in patients with carotid artery stenosis. Neurosurgery 2004;55(1):63-67.
10. Ogasawara K, Ito H, Sasoh M, et al. Quantitative measurement of regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p- iodoamphetamine autoradiography with SPECT: validation study using H2 15O with PET. J Nucl Med 2003;44(4):520-525.
11. Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N. Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 2004;25(2):242-247.
12. Saito H, Ogasawara K, Suzuki T, et al. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion singlephoton emission computed tomography in patients with major cerebral artery stenoocclusive diseases. Neurol Med Chir (Tokyo) 2011;51(7):479-483.
13. Sasse SA, Berry RB, Nguyen TK, Light RW, Mahutte CK. Arterial blood gas changes during breath-holding from functional residual capacity. Chest 1996;110(4):958-964.
14. Totaro R, Marini C, Baldassarre M, Carolei A. Cerebrovascular reactivity evaluated by transcranial Doppler: reproducibility of different methods. Cerebrovasc Dis 1999;9(3):142-145.
15. Mark CI, Slessarev M, Ito S, Han J, Fisher JA, Pike GB. Precise control of end-tidal carbon dioxide and oxygen improves BOLD and ASL cerebrovascular reactivity measures. Magn Reson Med 2010;64(3):749-756.
16. Mandell DM, Han JS, Poublanc J, et al. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke 2008;39(7):2021-2028.
17. Cohen-Adad J, Gauthier CJ, Brooks JC, et al. BOLD signal responses to controlled hypercapnia in human spinal cord. Neuroimage 2010;50(3):1074-1084.
18. Fierstra J, Spieth S, Tran L, et al. Severely impaired cerebrovascular reserve in patients with cerebral proliferative angiopathy. J Neurosurg Pediatr 2011;8(3):310-315.
19. Slessarev M, Han J, Mardimae A, et al. Prospective targeting and control of endtidal CO2 and O2 concentrations. J Physiol 2007;581(Pt 3):1207-1219.
20. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29(3):162-173.
21. Vorstrup S, Brun B, Lassen NA. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. Stroke 1986;17(6):1291-1298.
22. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood fow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001;21(12):1472-1479.
23. Dahl A, Russell D, Rootwelt K, Nyberg-Hansen R, Kerty E. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood fow measurements: dose, serum concentration, and time course of the response to acetazolamide. Stroke 1995;26(12):2302-2306.
24. Grossmann WM, Koeberle B. The doseresponse relationship of acetazolamide on the cerebral blood fow in normal subjects. Cerebrovasc Dis 2000;10(1):65-69.
25. Ringelstein EB, Van Eyck S, Mertens I. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab 1992;12(1):162-168.
26. Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994;150(6 Pt 1):1722-1737.
27. O'Croinin D, Ni Chonghaile M, Higgins B, Laffey JG. Bench-to-bedside review: permissive hypercapnia. Crit Care 2005;9(1):51-59.
28. Otten M, Schwarte LA, Oosterhuis JW, Loer SA, Schober P. Hypercapnic coma due to spontaneous pneumothorax: case report and review of the literature. J Emerg Med 2012;42(1):e1-e6.
29. Hoskins PR. Measurement of arterial blood fow by Doppler ultrasound. Clin Phys Physiol Meas 1990;11(1):1-26.
30. Kastrup A, Krüger G, Glover GH, Neumann-Haefelin T, Moseley ME. Regional variability of cerebral blood oxygenation response to hypercapnia. Neuroimage 1999;10(6):675-681.
31. Silvestrini M, Vernieri F, Troisi E, et al. Cerebrovascular reactivity in carotid artery occlusion: possible implications for surgical management of selected groups of patients. Acta Neurol Scand 1999;99(3):187-191.
32. Swanson GD. Dynamic forcing in the study of the human respiratory system. Stanford, Calif: Stanford University, 1972.
33. Robbins PA, Swanson GD, Howson MG. A prediction-correction scheme for forcing alveolar gases along certain time courses. J Appl Physiol 1982;52(5):1353-1357.
34. Wise RG, Pattinson KT, Bulte DP, et al. Dynamic forcing of end-tidal carbon dioxide and oxygen applied to functional magnetic resonance imaging. J Cereb Blood Flow Metab 2007;27(8):1521-1532.
35. Beaudin AE, Brugniaux J V, Vöhringer M, et al. Cerebral and myocardial blood fow responses to hypercapnia and hypoxia in humans. Am J Physiol Heart Circ Physiol 2011;301(4):H1678-H1686.
36. Sommer LZ, Iscoe S, Robicsek A, et al. A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoea. Eur Respir J 1998;12(3):698-701.
37. Somogyi RB, Vesely AE, Preiss D, et al. Precise control of end-tidal carbon dioxide levels using sequential rebreathing circuits. Anaesth Intensive Care 2005;33(6):726-732.